MHLW Adds Label Warnings To Astellas Protopic Ointment
This article was originally published in PharmAsia News
Japan's Ministry of Health, Labor and Welfare added warning information to Astellas' atopic dermatitis drug Protopic (tacrolimus) ointment Sept. 25. The ministry ordered the company to add in the warning label that even though no link has been found, cases of lymphoma and skin cancer were reported. The ministry cited that there is on average one such case reported in Japan every year. (Click here for more - Japanese language
You may also be interested in...
Mexico's Genomma Lab recorded strong double-digit growth for its OTC business in the second quarter as sales more than doubled at its US consumer health operation.
New board directors named at Autolus Therapeutics, Beximco Pharmaceuticals, Tetraphase Pharmaceuticals and Vesigen.
After launching a biosimilar to Avastin (bevacizumab) in India, Cadila Pharma has now also launched rituximab and teriparatide biosimilars in its domestic market.